Delhivery shares fall over 2% as Jefferies downgrades to ‘Underperform', slashes target price to Rs 315
By Aman Shukla Published on June 20, 2025, 09:26 IST
Shares of Delhivery slipped over 2% in early trade after global brokerage Jefferies downgraded the logistics firm to Underperform . The firm also sharply cut its price target on the stock from ₹500 to ₹315, citing slower growth expectations and competitive headwinds in the express parcel segment. As of 9:25 AM, the shares were trading 1.89% lower at Rs 348.55.
Jefferies now estimates a compound annual growth rate (CAGR) of 10% in express parcel industry volumes for FY25–30e, significantly lower than the 30% CAGR seen during FY20–25e. According to the brokerage, the recent 41% rally in Delhivery shares, post the e-Comm Express acquisition, has largely priced in optimism around industry consolidation.
However, Jefferies warned that rising insourcing by platforms like Meesho may impact Delhivery's third-party logistics (3PL) express parcel business. The brokerage also expects the company's market share in the 3PL segment to halve to around 34% by FY28e.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Dreamfolks shares recover 11% from intraday lows after company confirms ‘no clients lost'
Dreamfolks Services stock rebounded 11% from its intraday low after the company clarified to CNBC-TV18 that it has not lost any clients. As of 11:29 AM, the shares were trading 2.94% higher at Rs 243.00. The company stated, 'All our contracts are in place, and it's business as usual for us.' This reassurance comes amid earlier media reports suggesting potential client exits. Investors took confidence in the clarification, helping the stock recover from steep losses. The stock had earlier dropped following a June 19 PTI report claiming major banks and card networks—including ICICI Bank, Axis Bank, and Mastercard—were considering ending aggregator partnerships with DreamFolks to work directly with airport lounge operators. The report also suggested others might follow suit. The company's clarification helped restore investor confidence. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
an hour ago
- Business Upturn
Sai Life Sciences begins commercial operations of expanded Unit IV facility in Bidar
Sai Life Sciences has recently informed exchanges that the company successfully commenced commercial operations of the second phase of its production block at the Unit IV facility in Bidar, Karnataka, as of June 19, 2025. This phase adds around 91 kL of manufacturing capacity, marking the completion of the company's planned 195 kL expansion project at the site, as outlined in its prospectus. With this addition, the total installed capacity at the Bidar facility now stands at approximately 640 kL. The expanded unit is fully equipped to manufacture Registered Starting Materials (RSMs), intermediates, and Active Pharmaceutical Ingredients (APIs), catering to both clinical development and commercial-scale supply. This strategic milestone strengthens Sai Life Sciences' manufacturing footprint and aligns with its long-term growth plans in the pharmaceutical sector. The company's enhanced infrastructure will support its global clientele with high-quality and scalable production capabilities. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
an hour ago
- Business Upturn
Dilip Buildcon secures Rs 1,341 crore tunnel project in Kerala from Konkan Railway
By Aman Shukla Published on June 20, 2025, 11:34 IST Dilip Buildcon Limited has announced the receipt of a Letter of Acceptance (LOA) from Konkan Railway Corporation Ltd for a significant infrastructure project in Kerala. The contract involves the construction of a twin-tube unidirectional tunnel with two lanes in each direction, along with a four-lane approach road. This project, awarded on an Engineering, Procurement & Construction (EPC) basis, aims to provide direct connectivity between Anakkampoyil, Kalladi, and Meppadi, covering a total stretch of 8.275 km under Package-II. The project is located in the Kozhikode and Wayanad districts of Kerala and is expected to be completed within 48 months. The total value of the contract stands at ₹1,341 crore, including GST. This is a domestic contract, and there is no related party involvement from the promoter group companies. The company has also announced the closure of its trading window as per SEBI regulations until 48 hours after this information becomes public. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
